100 related articles for article (PubMed ID: 8951301)
1. Outcomes of Aminopenicillin Therapy for Vancomycin-Resistant Enterococcal Urinary Tract Infections.
Cole KA; Kenney RM; Perri MB; Dumkow LE; Samuel LP; Zervos MJ; Davis SL
Antimicrob Agents Chemother; 2015 Dec; 59(12):7362-6. PubMed ID: 26369973
[TBL] [Abstract][Full Text] [Related]
2. Promiscuous, persistent and problematic: insights into current enterococcal genomics to guide therapeutic strategy.
Hourigan D; Stefanovic E; Hill C; Ross RP
BMC Microbiol; 2024 Mar; 24(1):103. PubMed ID: 38539119
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin-resistant enterococcus bloodstream infection successfully managed with oritavancin and fosfomycin as sequential treatment.
Di Cecco C; Monticelli J; Di Bella S; Di Maso V; Luzzati R
J Chemother; 2024 Feb; 36(1):31-34. PubMed ID: 37602423
[TBL] [Abstract][Full Text] [Related]
4. Bioactivity-Based Molecular Networking-Guided Isolation of Epicolidines A-C from the Endophytic Fungus
Chang S; Li Y; Huang X; He N; Wang M; Wang J; Luo M; Li Y; Xie Y
J Nat Prod; 2024 May; ():. PubMed ID: 38785214
[TBL] [Abstract][Full Text] [Related]
5. Therapeutics for Vancomycin-Resistant Enterococcal Bloodstream Infections.
Cairns KA; Udy AA; Peel TN; Abbott IJ; Dooley MJ; Peleg AY
Clin Microbiol Rev; 2023 Jun; 36(2):e0005922. PubMed ID: 37067406
[TBL] [Abstract][Full Text] [Related]
6. First molecular characterization of related cases of healthcare-associated infections involving multidrug-resistant
Benammar S; Pantel A; Aujoulat F; Benmehidi M; Courcol R; Lavigne JP; Romano-Bertrand S; Marchandin H
Infect Drug Resist; 2018; 11():1483-1490. PubMed ID: 30271181
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin resistant enterococci in urine cultures: Antibiotic susceptibility trends over a decade at a tertiary hospital in the United Kingdom.
Toner L; Papa N; Aliyu SH; Dev H; Lawrentschuk N; Al-Hayek S
Investig Clin Urol; 2016 Mar; 57(2):129-34. PubMed ID: 26981595
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin-resistant Enterococcus faecium: catheter colonization, esp gene, and decreased susceptibility to antibiotics in biofilm.
Raad II; Hanna HA; Boktour M; Chaiban G; Hachem RY; Dvorak T; Lewis R; Murray BE
Antimicrob Agents Chemother; 2005 Dec; 49(12):5046-50. PubMed ID: 16304171
[TBL] [Abstract][Full Text] [Related]
9. The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis.
Mannis MJ
Trans Am Ophthalmol Soc; 2002; 100():243-71. PubMed ID: 12545697
[TBL] [Abstract][Full Text] [Related]
10. Nitrofurantoin is active against vancomycin-resistant enterococci.
Zhanel GG; Hoban DJ; Karlowsky JA
Antimicrob Agents Chemother; 2001 Jan; 45(1):324-6. PubMed ID: 11120989
[TBL] [Abstract][Full Text] [Related]
11. Quinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections.
Lamb HM; Figgitt DP; Faulds D
Drugs; 1999 Dec; 58(6):1061-97. PubMed ID: 10651391
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of quinupristin-dalfopristin in continuous ambulatory peritoneal dialysis patients.
Johnson CA; Taylor CA; Zimmerman SW; Bridson WE; Chevalier P; Pasquier O; Baybutt RI
Antimicrob Agents Chemother; 1999 Jan; 43(1):152-6. PubMed ID: 9869581
[TBL] [Abstract][Full Text] [Related]
13. Reducing vancomycin use utilizing a computer guideline: results of a randomized controlled trial.
Shojania KG; Yokoe D; Platt R; Fiskio J; Ma'luf N; Bates DW
J Am Med Inform Assoc; 1998; 5(6):554-62. PubMed ID: 9824802
[TBL] [Abstract][Full Text] [Related]
14. Treatment of vancomycin-resistant Enterococcus faecium infections.
Lai KK
Arch Intern Med; 1996 Dec 9-23; 156(22):2579-84. PubMed ID: 8951301
[TBL] [Abstract][Full Text] [Related]
15. Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium.
Winston DJ; Emmanouilides C; Kroeber A; Hindler J; Bruckner DA; Territo MC; Busuttil RW
Clin Infect Dis; 2000 May; 30(5):790-7. PubMed ID: 10817685
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
[TBL] [Abstract][Full Text] [Related]
17. Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia.
Erlandson KM; Sun J; Iwen PC; Rupp ME
Clin Infect Dis; 2008 Jan; 46(1):30-6. PubMed ID: 18171210
[TBL] [Abstract][Full Text] [Related]
18. Treatment options for vancomycin-resistant enterococcal infections.
Linden PK
Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
